BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

iScience Interventional Enters into a Collaborative Supply Agreement with Centocor Research And Development, Inc. on a Minimally-Invasive Approach to Deliver Cell Therapies


4/7/2010 7:14:53 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--iScience Interventional, pioneers of site-specific therapies for anterior and posterior ocular diseases, announced it has signed a collaborative agreement with Centocor R&D, Inc. iScience will supply micro-catheter delivery systems for use in the clinical evaluation of cell therapies used in the treatment of retinal degeneration.

“We are pleased to work with Centocor in exploring the new site-specific therapeutic opportunities enabled by this access device,” commented Michael F. Nash, President & CEO of iScience Interventional. “We believe that the iTrack™ family of micro-catheters will have a significant role in the creation of numerous treatments for unmet clinical needs that dramatically impact patients vision. The advent of micro-catheter technology provides unprecedented access to anatomical structures in both the anterior and posterior segments of the eye.”

About iScience Interventional

The iTrack™ 275 is one of a platform of novel devices dedicated to the pursuit and growth of minimally invasive ophthalmic procedures. Interventional ophthalmology has changed the way patients around the world are receiving care through the utilization of iScience Interventional’s microsurgical instruments and imaging equipment. In addition to giving glaucoma patients an advanced minimally-invasive surgical option, the Company has also launched several new products for retina surgery within the past year.

Contact:

Pascale Communications, LLC Allison Potter, 814-221-2661 allison@pascalecommunications.com Or: Massell Communications June Massell, 212-717-4344 jmassell@aol.com

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES